지씨지놈

340450KOSDAQ

59.8 / 100

Reference Date: 2026-09-08

Financial Score20.5 / 40

News Sentiment21.3 / 25

Momentum8.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health. Rose 5.2% over the past month, and news sentiment is neutral.

Company InformationBased on 2025 Annual Report

Business Overview

GC Genomics is a clinical genomics analysis company established in 2013, specializing in developing precision medicine technologies that utilize genomic big data for disease prevention and personalized treatment. Its core business includes four areas: prenatal/neonatal screening, cancer precision diagnosis, rare disease diagnosis, and health check-ups, with services provided to over 1,000 medical institutions domestically and 22 countries globally, solidifying its market position internationally.

Number of Employees

131people

Average Salary

53.2M KRW

Score Calculation Basis

Detailed Financial Score

PER

29.73Industry Average 15.001.5Point

2.0x industry avg (risky)

PBR

1.66Industry Average 1.202.5Point

Higher than industry avg (caution)

ROE

7.26Industry Average 8.002.5Point

Below industry avg

Debt Ratio

4.62Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 6.0 / 10 points

Revenue Growth Rate

1.5 / 3

Operating Profit Growth Rate

1.5 / 3

ROE Trend

3.0 / 4

Detailed News Sentiment

2 totalPositive 2Neutral 0Negative 0Average Sentiment Score 85

Positive
지씨지놈, 상반기 역대 최대 실적…영업익 119% 증가
지씨지놈의 상반기 실적이 역대 최대치를 기록하며 매출과 영업이익이 크게 증가했다.
Positive
GC지놈 상반기 매출 157억, 전년比 8% 증가
GC지놈의 상반기 매출과 영업이익이 각각 전년 대비 8%와 119% 증가하여 긍정적인 실적 개선을 보고했다.

Detailed Momentum

52-week position3.0Point

52w lower range (23%)

Current 5,500Won52-week high 9,31052-week low 4,310

1-month return4.0Point

1m +5.16% (slight rise)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0

Neutral반기보고서 (2026.06)2026-08-14